Sunshine Biopharma Stock Quote SBFM - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.34

Bid

0.34

Ask

0.3499

Volume

685,787

0.33 Day's Range 0.355

0.2811 52 Week Range 64.50

Market Cap

6.521M

Previous Close

0.3442

Open

0.3468

Last Trade

900

0.34

(formt)

Last Trade Time

Financial Volume

$ 235,956

VWAP

0.344067

Average Volume (3m)

4,746,008

Shares Outstanding

18,945,052

Dividend Yield

PE Ratio

-1.43

Earnings Per Share (EPS)

-0.24

Revenue

24.09M

Net Profit

-4.51M

Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of ... Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of the licensed Adva-27a anticancer drug, a small molecule that has been shown to be exceptionally effective at destroying Multidrug-Resistant Cancer Cells, including Pancreatic Cancer cells (Panc-1), Small-Cell Lung Cancer cells (H69AR), Breast Cancer cells (MCF-7/MDR) and Uterine Sarcoma cells (MES-SA/Dx5). Show more

Sector

Coml Physical, Biologcl Resh

Industry

Coml Physical, Biologcl Resh

Website

www.sunshinebiopharma.com

Headquarters

Montreal, Quebec, Can

Founded

1970

Sunshine Biopharma Inc is listed in the Coml Physical, Biologcl Resh sector of the NASDAQ with ticker SBFM. The last closing price for Sunshine Biopharma was $0.34. Over the last year, Sunshine Biopharma shares have traded in a share price range of $ 0.2811 to $ 64.50.

Sunshine Biopharma currently has 18,945,052 shares outstanding. The market capitalization of Sunshine Biopharma is $6.52 million. Sunshine Biopharma has a price to earnings ratio (PE ratio) of -1.43.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.02	6.25	0.32	0.3798	0.2867	1038378	0.34794994	CS
4	0.0557	19.5919803025	0.2843	0.468	0.282	3668484	0.37955354	CS
12	-3.21	-90.4225352113	3.55	3.68	0.2811	4746008	0.81961396	CS
26	-24.85	-98.6502580389	25.19	28.56	0.2811	14254542	7.26079118	CS
52	-49.66	-99.32	50	64.5	0.2811	7068888	7.61913718	CS
156	-274.66	-99.8763636364	275	987	0.2811	4505169	159.84218377	CS
260	-274.66	-99.8763636364	275	987	0.2811	4505169	159.84218377	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
LCFYLocafy Ltd	$ 6.10 (162.92%)	46.08M
KZIAKazia Therapeutics Ltd	$ 1.24 (85.57%)	215.06M
CYNCYNGN Inc	$ 7.20 (81.82%)	17.89M
NEXINexImmune Inc	$ 3.84 (66.23%)	34.48M
BDRXBiodexa Pharmaceuticals PLC	$ 1.08 (51.88%)	59.99M
CETUUCetus Capital Acquisition Corporation	$ 7.00 (-29.72%)	1.42k
TRIBTrinity Biotech PLC	$ 2.046 (-28.96%)	81.02k
CINGCingulate Inc	$ 0.4845 (-25.23%)	1.33M
IVPInspire Veterinary Partners Inc	$ 5.5842 (-24.54%)	2.35M
SLRXSalarius Pharmaceuticals Inc	$ 2.12 (-22.70%)	1.99M
NVDANVIDIA Corporation	$ 127.40 (-5.57%)	362.02M
MAXNMaxeon Solar Technologies Ltd	$ 0.24 (13.85%)	349.82M
TSLATesla Inc	$ 241.03 (-8.44%)	217.69M
KZIAKazia Therapeutics Ltd	$ 1.24 (85.57%)	215.06M
SQQQProShares UltraPro Short QQQ	$ 7.63 (6.42%)	178.49M